Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors

Overview of attention for article published in Frontiers in Bioengineering and Biotechnology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,965 followers.

Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors https://t.co/fvvweFX7AK https://t.co/XYIgGX7dYL

New Research: Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors https://t.co/14qkxQbI2m #bioengineering #biotech

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.